St. Elisabeth-Krankenhaus Köln-Hohenlind

Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung – An AIO phase Ib/II trial (2026) Reck M, Waller C, Sadjadian P, Kambartel K, Grohé C, Sendler A, Reinmuth N, et al. Journal article Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Persistent HPV Infections and Squamous Cell Lesions: Evaluation of over 10000 Patients Registerstudie der Arbeitsgemeinschaft Zervixpathologie und Kolposkopie e. V. (AGCPC) zum Abkl"rungsalgorithmus im neuen Zervixkarzinomscreening - HPV-Persistenz und plattenepitheliale L"sionen: Evaluation von über 10000 Patientinnen (2026) Henes M, Mann E, Hirchenhain C, Kentner A, Selgrad C, Hampl M, Keyver-Paik MD, et al. Journal article Lethal complication of a rare cardiac tumor (2024) Siegel S, Claus L, Kamphausen T, Feld K Journal article Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial (2022) Trapp EK, Fasching P, Fehm T, Schneeweiss A, Mueller V, Harbeck N, Lorenz R, et al. Journal article Subtype specific expression of radioligand targets in the prospective Real World clinico-pathological register trial BRIDGister (2022) Wirtz R, Friedersdorff F, Barski D, Otto T, Bug R, Veltrup E, Kilic E, et al. Conference contribution Model curriculum of the German society for Rheumatology for advanced training in the discipline internal medicine and rheumatology. English version (2021) Pfeil A, Krusche M, Vossen D, Berliner MN, Keysser G, Krause A, Lorenz HM, et al. Journal article Sample Curriculum of the German Society for Rheumatology for Advanced Training in the field of Internal Medicine and Rheumatology (2021) Pfeil A, Krusche M, Vossen D, Berliner MN, Keyer G, Krause A, Lorenz HM, et al. Journal article, Editorial Krt20, krt5, esr1 and erbb2 expression can predict pathologic outcome in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (2021) Jütte H, Reike M, Wirtz RM, Kriegmair M, Erben P, Tully K, Weyerer V, et al. Journal article Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non–muscle-invasive Bladder Cancer: A Case Report (2021) Weiß S, Hallmann S, Koch S, Eidt S, Stöhr R, Veltrup E, Roggisch J, et al. Journal article Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC) (2020) Breyer J, Monga M, Mayr R, Otto W, Burger M, Eckstein M, Stöhr R, et al. Conference contribution